Sip Wijchers: Is It Time to Use Ultrasound for Every AF Ablation Access?
Sip Wijchers, Cardiologist-electrophysiologist at Erasmus MC, shared a post on LinkedIn:
”We’ve optimized anticoagulation in AF ablation. But what about the puncture?
Vascular access complications remain the most common adverse event in AF ablation. And yet, many labs still rely on landmark-based femoral venous access.
The ULYSSES trial challenges that habit.
In 986 patients undergoing AF/LA tachycardia ablation, ultrasound-guided access reduced clinically relevant vascular complications from 3.3% to 0.6% (RR 0.19, p=0.002) (Schaack et al., 2026).
But the real signal may be elsewhere:
- Arterial puncture: 16% – 2%
- Failed venous access: 8.2% – 0.2%
- No increase in procedure time
This is not about marginal gains.
This is about predictability and safety at the very first step of the procedure.
And importantly, this aligns with decades of data across vascular access:
Ultrasound improves success and reduces complications in central lines, subclavian access, and femoral arterial puncture (Teja et al., 2024; Zawadka et al., 2023; Strauss et al., 2025).
So the real question is no longer does it help?
It’s:
Can we still justify not using it?
- Yes, the absolute risk reduction is modest.
- Yes, the trial was stopped early.
But when a low-cost, widely available tool reduces the most frequent complication of a high-volume procedure… the bar for “routine use” should be low.
Should ultrasound-guided femoral venous access now be the default in AF ablation?
Or is palpation still acceptable in experienced hands?
Curious how this is implemented in your lab.”

Stay updated with Hemostasis Today.
-
Aug 14, 2026, 08:17Maha Othman: Celebrating Research and Collaboration at the Sinclair Cancer Research Institute 2026 Annual Retreat
-
Aug 14, 2026, 06:26Delivering Gene Therapy in Hemophilia – ISTH
-
Aug 13, 2026, 18:39Lukas Röthlisberger: Real-World Evidence on Effectiveness and Safety of Rivaroxaban in Children
-
Aug 13, 2026, 18:36Soner Yilmaz: Blood Safety in Türkiye Through More Than 22.5 Million Blood Donations
-
Aug 13, 2026, 18:31Muthukumarasamy Raja: FDA Approval of EZPLAZ Marks a Breakthrough in Emergency Plasma Care
-
Aug 13, 2026, 18:29Peter Zdziarski: Protecting Our Community While Creating a Future Where We Are No Longer Needed
-
Aug 13, 2026, 18:29Morgan E Amos: Thrilled to Receive the Student Research Award From HTRS
-
Aug 13, 2026, 16:38Sheharyar Raza: Plasma Exchange in Multiple Sclerosis
-
Aug 13, 2026, 16:31Juan Manuel Cisneros Carrasco: The True Cost of Blood Donation